Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cumberland Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CPIX
Nasdaq
2834
www.cumberlandpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cumberland Pharmaceuticals Inc.
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
- May 6th, 2026 8:12 am
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
- May 6th, 2026 6:30 am
Cumberland Pharmaceuticals Q1 Earnings Call Highlights
- May 5th, 2026 5:43 pm
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
- May 5th, 2026 3:00 pm
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex
- May 5th, 2026 6:17 am
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
- Apr 28th, 2026 2:05 pm
Broadwind And 2 Promising Penny Stocks For Your Investment Radar
- Apr 24th, 2026 12:05 pm
Cumberland to sell drug portfolio to Apotex for $100m
- Apr 24th, 2026 4:14 am
Cumberland Pharmaceuticals jumps on $100M Apotex transaction
- Apr 23rd, 2026 8:52 am
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses
- Apr 23rd, 2026 7:15 am
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
- Apr 23rd, 2026 7:00 am
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
- Apr 22nd, 2026 6:00 am
CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
- Apr 16th, 2026 7:05 am
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
- Mar 17th, 2026 7:05 am
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
- Mar 10th, 2026 11:49 am
Cumberland Pharmaceuticals Inc (CPIX) Q4 2025 Earnings Call Highlights: Revenue Surge and ...
- Mar 3rd, 2026 10:01 pm
Cumberland Pharmaceuticals Q4 Earnings Call Highlights
- Mar 3rd, 2026 4:02 pm
Cumberland: Q4 Earnings Snapshot
- Mar 3rd, 2026 3:15 pm
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
- Mar 3rd, 2026 3:00 pm
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®
- Feb 25th, 2026 5:00 am
Scroll